Idenix

Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
This Week in Biotech
Motley Fool
Sun, 06/23/13 - 11:11 am
Nektar
NKTR-181
pain management
Novartis
serelaxin
Idenix
IDX20963
hepatitis C
ViroPharma
JNJ
Aragon
ARN-509
prostage cancer
Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again
Motley Fool
Sat, 06/22/13 - 09:46 am
Idenix
IDX20963
hepatitis C
Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials
Yahoo/AP
Fri, 06/21/13 - 09:16 am
Idenix
FDA
hepatitis C
IDX20963
Idenix Pharma Initiates Phase II Study
Yahoo/Zacks
Sat, 06/1/13 - 12:06 pm
Idenix
hepatitis C
hepatitis
samatasvir
IDX719
simeprevir
TMC435
JNJ
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tue, 04/16/13 - 11:55 am
sofosbuvir
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Merck
Idenix
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 03/30/13 - 10:34 am
Ziopharm
Idenix
Vanguard Health Systems
Idenix Pharma shares sink after regulators determine competitor filed drug patent first
Yahoo/AP
Tue, 03/26/13 - 10:28 am
Gilead Pharmasset
patents
Idenix
Idenix Loses First Phase Of Patent Dispute With Gilead Sciences
TheStreet.com
Mon, 03/25/13 - 12:05 pm
Gilead
Idenix
patents
hepatitis C
sofosbuvir
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Sat, 03/23/13 - 08:52 am
Gilead Pharmasset
Idenix
hepatitis C
patents
Idenix Reports In-Line 4Q Loss
Yahoo/Zacks
Fri, 03/1/13 - 11:47 am
earnings
Idenix
Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds
Yahoo/AP
Tue, 02/5/13 - 10:38 am
Idenix
hepatitis C
IDX184
IDX19368
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 01/12/13 - 10:38 am
Arqule
Sequenom
Idenix
Idenix May Drop Delayed Hepatitis C Drug for New Versions
Bloomberg
Thu, 01/10/13 - 09:02 am
Idenix
hepatitis C
IDX-184
IDX-19368
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
Idenix Gets a Big Buy Rec
Motley Fool
Thu, 11/29/12 - 10:36 am
Idenix

Pages